Literature DB >> 19401477

Community pharmacist-provided extended diabetes care.

William R Doucette1, Matthew J Witry, Karen B Farris, Randal P McDonough.   

Abstract

BACKGROUND: Pharmacists in various settings have been effective in initiating diabetes treatment. Patients with diabetes require ongoing disease management, and community pharmacists are in a strategic position to provide such extended care. Little is known, however, about the effects of community pharmacist-provided interventions beyond the initial treatment period.
OBJECTIVE: To evaluate the effect of community pharmacist-provided extended diabetes care service on primary clinical outcomes, including hemoglobin A(1c) (A1C), low-density lipoprotein cholesterol (LDL-C), and blood pressure, and on patients' reported self-care activities.
METHODS: A randomized controlled trial was conducted in patients with diabetes. Participants had already completed at least 2 diabetes education sessions at a local diabetes education center. Nine specially trained pharmacists administered interventions during up to 4 quarterly visits per patient. Interventions included discussing medications, clinical goals, and self-care activities with patients and recommending medication changes to physicians when appropriate. The main outcome measures were 12-month changes in A1C, LDL-C, blood pressure, and self-report of self-care activities.
RESULTS: Seventy-eight patients participated in the study (36 intervention, 42 control); 66 were included in the final analysis (31 intervention, 35 control). Compared with changes in the control group, patients who received interventions significantly increased the number of days per week that they engaged in a set of diet and diabetes self-care activities (1.25 and 0.73 more days/wk, respectively). The mean 12-month changes for A1C, LDL-C, and blood pressure were not significantly different between the 2 study groups.
CONCLUSIONS: Although pharmacist-provided interventions did not demonstrate statistically significant improvements in clinical outcomes over the study period, study results did show that pharmacists were effective at increasing the number of days that patients spent engaging in healthy diet and diabetes self-care activities. Addressing lifestyle and self-care behaviors can be a beneficial component of a pharmacist-provided extended diabetes care service.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401477     DOI: 10.1345/aph.1L605

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  25 in total

1.  Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

Authors:  Amir H Zargarzadeh; Susan Jacob; Roger S Klotz; Fadi T Khasawneh
Journal:  Int J Clin Pharm       Date:  2011-12

2.  Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists.

Authors:  Katherine J Overwyk; Steven P Dehmer; Kakoli Roy; Michael V Maciosek; Yuling Hong; Madeleine M Baker-Goering; Fleetwood Loustalot; Christa-Marie Singleton; Matthew D Ritchey
Journal:  Med Care       Date:  2019-11       Impact factor: 2.983

3.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

Review 4.  Effectiveness of disease-management programs for improving diabetes care: a meta-analysis.

Authors:  Clément Pimouguet; Mélanie Le Goff; Rodolphe Thiébaut; Jean François Dartigues; Catherine Helmer
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

Review 5.  The effect of community pharmacy-based interventions on patient health outcomes: a systematic review.

Authors:  Susan J Blalock; Andrew W Roberts; Julie C Lauffenburger; Trey Thompson; Shanna K O'Connor
Journal:  Med Care Res Rev       Date:  2012-10-02       Impact factor: 3.929

Review 6.  The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ejaz Cheema; Paul Sutcliffe; Donald R J Singer
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

Review 7.  A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management.

Authors:  Michael P Conley; Christine Chim; Chelsea E Magee; Daniel J Sullivan
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

8.  Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong.

Authors:  Joyce H You; Fiona Y Wong; Frank W Chan; Eliza L Wong; Eng-Kiong Yeoh
Journal:  BMC Clin Pharmacol       Date:  2011-11-25

Review 9.  Care management for Type 2 diabetes in the United States: a systematic review and meta-analysis.

Authors:  Jason S Egginton; Jennifer L Ridgeway; Nilay D Shah; Saranya Balasubramaniam; Joann R Emmanuel; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  BMC Health Serv Res       Date:  2012-03-22       Impact factor: 2.655

10.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Authors:  Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.